Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C07BB07	BISOCOR 5 PLUS	G	Bisoprolol - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	678,321 L.L
L01EA04	BOSULIF	B	Bosutinib - 100mg	100mg	Tablet, film coated	L.L
B01AC24	BRILINTA	B	Ticagrelor - 90mg	90mg	Tablet, film coated	5,544,694 L.L
M05BA06	BONVIVA	B	Ibandronic acid - 150mg	150mg	Tablet, film coated	1,265,900 L.L
M05BA06	BONAFOR	G	Ibandronic acid (monosodium monohydrate) - 150mg	150mg	Tablet, film coated	383,955 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 5mg	5mg	Tablet, film coated	1,237,679 L.L
C01EB17	BRADIREM	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,134,203 L.L
C01EB17	BRAVIGO	G	Ivabradine (HCl) - 7.5mg	7.5mg	Tablet, film coated	1,237,679 L.L
C07AB07	BISOPROLOL QUIVER LAB	G	Bisoprolol fumarate - 5mg	5mg	Tablet, film coated, scored	264,737 L.L
C07AB07	BISOPROLOL QUIVER LAB	G	Bisoprolol fumarate - 10mg	10mg	Tablet, film coated, scored	526,786 L.L
A16AX	BICANORM	G	Sodium bicarbonate - 1000mg	1000mg	Tablet, gastroresistant	2,623,181 L.L
G04BD12	BETMIGA	B	Mirabegron - 50mg	50mg	Tablet, prolonged release	3,758,727 L.L
M01AE03	BI-PROFENID LP	B	Ketoprofen - 100mg	100mg	Tablet, prolonged release	392,402 L.L
N05BA08	BROMAZEPAM BIOGARAN	G	Bromazepam - 6mg	6mg	Tablet, scored	180,075 L.L
M01AC01	BREXIN	B	Piroxicam-β-cyclodextrin - 20mg	20mg	Tablet, scored	971,598 L.L
N04AA01	BENZHEXOL	G	Trihexyphenidyl - 5mg	5mg	Tablet, scored	533,697 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	692,079 L.L
A03BB01	BUSCOPAN	B	Butylscopolamine bromide - 10mg	10mg	Tablet, sugar coated	291,614 L.L
A03CA02	BIPAX	G	Clidinium bromide - 2.5mg, Chlordiazepoxide - 5mg		Tablet, sugar coated	363,477 L.L

...